ArticleESMO gastrointestinal oncology2025
Retreatment with oxaliplatin-based regimens in refractory metastatic colorectal cancer: characterization of high-response patients.
F Salvà et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.